OS Therapies Incorporated

AMEX:OSTX

Biotechnology

Healthcare
$1.15 +5.81%

+$0.10 today

Market cap
$53.83M
Beta
-0.95
P/E (TTM)
-2.0
EPS (TTM)
-$0.91
52W Low $1.15High $2.57

Volume 0.50M

Average 0.71M

Returns on capital

OS Therapies Incorporated management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

572.2%

avg -64.9%

ROIC

582.9%

avg 18.9%

ROA

-420.4%

avg -843.8%

Analysis

ROIC is currently the strongest return metric at 582.9% versus its period average of 18.9%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Paul A. Romness

Founder, Chairman, President & Chief Executive OfficerUSD 722.17K60900.00K2.02%

Robert G. Petit

Chief Medical Officer & Chief Scientific OfficerUSD 420K66——

Christopher Acevedo

Chief Financial OfficerUSD 36K63——

Jack Doll

Chief of Staff————

Gerald E. Commissiong

Chief Business Officer—44——

Compensation is shown in the reported currency; data updated Oct 3, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 22, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does OS Therapies Incorporated compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about OSTX's management, answered from reported figures.

Who manages OSTX?

OS Therapies Incorporated (OSTX) lists 5 active executives. The top listed executive is Jack Doll, Chief of Staff.

Are OSTX insiders buying or selling?

Recent insider activity shows net buying of $48.07B.